http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2420292-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da54f7ebbd2d9d8a82f92aca4d1b4e48
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57
filingDate 2001-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f35ea76c267ec8fde57741485a059f1
publicationDate 2002-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2420292-A1
titleOfInvention Contraception process and administration form for the same
abstract Process for hormonal contraception, in which in a plurality of substantially time-unlimited, linked taking periods and optionally having a sequence lasti ng several years and which in each case comprise at least one taking cycle with a duration-constant taking phase lasting several days within the particular taking period and a taking pause lasting several days, in which taking phase or phases per day administration takes place of a daily unit with at least o ne contraceptively acting hormone component, such as estrogen and/or gestagen, and in the taking pause or pauses administration takes place either of placebos free from any hormone component or the particular taking pause remains entirely administration-free and the duration of the taking phase or phases of at least the final taking period last at least 22 days, characterized in that the duration of the taking phase or phases in any taki ng period proceding a following taking period is shorter than in each case following taking period, as well as administration form for hormonal contraception and in particular for the performance thereof.
priorityDate 2000-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578152
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9324
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419581161
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5991
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491871
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506267
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68861
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360970
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903349
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID93052
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5857
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535678
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419479706
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493514
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID175
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503777
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419541440
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554556
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419591920
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553695
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6279
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6230
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3033968
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5757
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554137
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID40973
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5832
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13109

Total number of triples: 61.